维普期刊资源整合服务平台（V6.5）

54篇 您的检索式：作者名="Balakumar M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions 显示文摘	Balakumar P Kaur T Singh M	2008	Toxicology2008，245，12：	1
2	Emerging role of PPAR lig- ands in the management of diabetic nephropathy显示文摘	Balakumar P Arora MK Singh M	2009	Pharmacol Res2009，60，3：	1
3	Effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats 显示文摘	Singh AP Singh M Balakumar P	2008	J Cardiovasc Pharmacol2008，51，6：	1
4	Ameliorative effect of combina-tion of benfotiamine and fenofibrate in diabetes-induced vascular endo-thelial dysfunction and nephropathy in the rat显示文摘	Balakumar P Chakkarwar VA Singh M		0，，1：	1
5	Effect of mast cell sta- bilizers in hyperhomocysteinemia - induced cardiac hypertrophy in rats显示文摘	SINGH A P SINGH M BALAKUMAR P	2008	J Cardiovasc Pharmaeol2008，51，6：	1
6	Emerging role of PPAR ligands in the management of diabetic nephropathy 显示文摘	Balakumar P Arora MK Singh M	2009	Pharmacol Res2009，60，3：	1
7	Amelinrative effct of com- bination of benfotiamine and fenofibrate in diabetes -induced vas- cular endothelial dysfunction and nephropathy in the rat 显示文摘	Balakumar P Chakkarwar VA Singh M	2009	Mol Cell Biochem2009，320，：	1
8	Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats 显示文摘	ROSE M BALAKUMAR P SINGH M	2007	Pharmacology2007，80，23：	1
9	Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions 显示文摘	BALAKUMAR P ARORA M K GANTISS	2009	Pharmacol Res2009，60，1：	1
10	Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats 显示文摘	ROSE M BALAKUMAR P SINGH M	2007	Pharmacology2007，80，23：	1
11	PPAR dual agonists: are they opening Pandora's Box?显示文摘	Balakumar P Rose M Ganti SS Krishan P Singh M	2007	Pharmacol Res2007，56，2：	1
12	Ameliorative effect of com-bination of fenofibrate and rosiglitazone in pressure overload - in-duced cardiac hypertrophy in rats显示文摘	Rose M Balakumar P Singh M etal	2007	Pharmacology2007，80，23：	1
13	PPAR dual agonist: are they opening Pandoraps BOX? 显示文摘	Balakumar P Rose M Ganti SS	2007	Pharmacol Res2007，56，2：	1
14	The possible role of caspase - 3 in path- ological and physiological cardiac hypertrophy in rats 显示文摘	Balakumar P Singh M	2006	Basic Clin Pharmacol Toxicol2006，99，6：	1
15	Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes- induced vascular endothelial dysfunction and nephropathy in the rat 显示文摘	Balakumar P Chakkarwar VA Singh M	2009	Mol Cell Biochem2009，320，12：	1
16	Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy显示文摘	Balakumar P Reddy J Singh M	2009	Mol Cell Bio- chem2009，330，12：	1
17	Possible role of caspase-3 in pathological and physiological cardiac hypertrophy in rats显示文摘	Balakumar P Singh M	2006	Basic Clin Pharmacol Toxicol2006，99，：	1
18	Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats显示文摘	Rose M Balakumar P Singh M	2007	Pharmacology2007，80，23：	1
19	Anti-TNF-α therapy in heart failure:future directions显示文摘	Balakumar P Singh M	2006	Basic Clin Pharmacol Toxicol2006，99，：	1
20	Peroxisome proliferator activated receptor agonists:emerging therapy for cardiovascular complications显示文摘	Balakumar P Rose M Singh M	2007	J Pharmacol Toxicol2007，2，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示